DESCRIPTION
Examination of the oral cavity provides valuable clues to a large number of systemic disorders. Gum hypertrophy is usually associated with myelomonocytic and monocytic subtypes of acute myeloid leukaemia. 1 Its occurrence in a case of acute promyelocytic leukaemia (APL) is unusual. 1 We describe a 28-year-old man from India who presented to our hospital with a 2-week history of easy fatiguability and gum bleeding. Examination revealed pallor and marked gum hypertrophy 
Learning points
▸ Examination of the orodental cavity must be included in a routine clinical examination. ▸ The presence of gum enlargement may provide a clue to an underlying malignancy. ▸ Gum hypertrophy may herald the diagnosis of acute promyelocytic leukaemia when associated with a characteristic coagulopathy (hypofibrinogenaemia) and abnormal promyelocytes in the blood. ▸ Immediate initiation of all-trans-retinoic acid and arsenic trioxide in such cases without waiting for molecular studies may be life-saving.
morphological remission (assessed by a repeat bone marrow examination) at the end of the induction phase. Molecular remission (PML-RARα not detectable by RT-PCR) at 6 weeks of therapy was also documented. He is currently planned for consolidation therapy. APL constitutes 5-13% cases of acute myeloid leukaemia. Bleeding is the predominant presentation and accounts for a high early mortality rate. 2 3 The incidence of gum hypertrophy in APL is varied in the literature, with the reported incidence being 5.7% and 20% in two retrospective studies from India. 2 3 Gum hypertrophy may be a clue to an underlying malignancy like APL and its presence must be sought by meticulous clinical examination. 
